drugset / Trial / NCT00297011

Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis

NCT00297011

Phase 2 Completed 300 enrolled University of Utah GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).

Timeline

Start
2004-09
Primary completion
2007-03
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Clobetasol Small molecule 0.05 % Topical
Subject Valacyclovir Unknown 2 g Oral

Indications